UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 68 filers reported holding UROGEN PHARMA LTD in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,483,200 | -24.0% | 320,000 | -43.9% | 1.46% | +3.4% |
| Q2 2023 | $5,899,500 | +26.4% | 570,000 | +12.9% | 1.41% | +0.9% |
| Q1 2023 | $4,666,200 | +7.7% | 505,000 | +3.3% | 1.40% | -7.2% |
| Q4 2022 | $4,334,379 | +31.1% | 488,656 | +22.9% | 1.51% | +10.3% |
| Q3 2022 | $3,307,000 | +69.2% | 397,500 | +66.5% | 1.37% | +55.1% |
| Q2 2022 | $1,955,000 | – | 238,670 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |